The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration’s Adverse Event Reporting System

OBJECTIVES: This study was designed to assess the disproportionality analyses of adverse drug reactions (ADRs) related to hydroxychloroquine and remdesivir and how ADR reporting fluctuated during the COVID-19 pandemic. METHODS: A retrospective observational study was conducted utilizing the Food and...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsuhaibani, Deemah S., Edrees, Heba H., Alshammari, Thamir M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232922/
https://www.ncbi.nlm.nih.gov/pubmed/37304358
http://dx.doi.org/10.1016/j.jsps.2023.05.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232922/
https://www.ncbi.nlm.nih.gov/pubmed/37304358
http://dx.doi.org/10.1016/j.jsps.2023.05.023

Ejemplares similares